Boston Scientific
1,150 hedge funds and large institutions have $77.5B invested in Boston Scientific in 2023 Q4 according to their latest regulatory filings, with 177 funds opening new positions, 443 increasing their positions, 377 reducing their positions, and 68 closing their positions.
160% more first-time investments, than exits
New positions opened: 177 | Existing positions closed: 68
18% more repeat investments, than reductions
Existing positions increased: 443 | Existing positions reduced: 377
10% more capital invested
Capital invested by funds: $70.6B → $77.5B (+$6.91B)
9% more funds holding
Funds holding: 1,057 → 1,150 (+93)
0.17% more ownership
Funds ownership: 91.34% → 91.51% (+0.17%)
5% less call options, than puts
Call options by funds: $513M | Put options by funds: $538M
7% less funds holding in top 10
Funds holding in top 10: 29 → 27 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$658M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$366M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$353M |
| 4 |
JP Morgan Chase
New York
|
+$242M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$152M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$650M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$301M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$286M |
| 4 |
Millennium Management
New York
|
-$201M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$166M |
BSX Hedge Fund Activity: Q4 2023 in Review
1,150 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2023, worth a combined $77.5B — up 9.8% from $70.6B a quarter earlier.
Buyers outnumbered sellers: 177 funds opened new BSX positions and 68 closed out — a net gain of 109 holders — while 443 added to existing stakes and 377 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $658M. The largest seller was Citadel Advisors, cutting an estimated $650M.
- 1,150 institutional investors held Boston Scientific (BSX) as of Q4 2023, up from 1,057 in Q3 2023.
- Funds reported $77.5B of Boston Scientific stock for Q4 2023, up 9.8% quarter-over-quarter.
- 177 funds opened new Boston Scientific positions in Q4 2023 and 68 closed out, a net change of +109 holders.
- The largest Boston Scientific buyer in Q4 2023 was Fidelity Investments, an estimated $658M added.
- The largest Boston Scientific seller in Q4 2023 was Citadel Advisors, an estimated $650M sold.
Based on aggregated 13F filings for Q4 2023.